Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DR Horton (DE:HO2)
FRANKFURT:HO2
Holding DE:HO2?
Track your performance easily
HO2 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€114.25 - €178.38
Previous Close€154.04
Volume0.00
Average Volume (3M)53.00
Market Cap
€50.13B
Enterprise Value€51.93B
Total Cash (Recent Filing)$4.52B
Total Debt (Recent Filing)$5.92B
Price to Earnings (P/E)―
Beta0.46
Next Earnings
Jan 28, 2025EPS Estimate
€2.25Last Dividend Ex-Date
Nov 12, 2024Dividend Yield0.73%
Share Statistics
EPS (TTM)N/A
Shares Outstanding321,169,526
10 Day Avg. Volume8
30 Day Avg. Volume53
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.02
Price to Sales (P/S)1.42
Price to Cash Flow (P/CF)18.90
P/FCF Ratio20.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.36
Enterprise Value/Gross Profit5.45
Enterprise Value/Ebitda4.17
Forecast
1Y Price Target
€180.38Price Target Upside17.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
DR Horton News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDHI's sustainable relative advantages remain firmly intact: deep local market-share positions, low-cost and efficient-production business model and breadth of geographic markets while carrying low leverage.
Market PositioningDHI is ideally positioned to capitalize on future conditions and take market share given its scale, leverage, and ability to deliver comparable product at the lowest price point.
Shareholder ReturnsPositively, DHI is returning cash through dividends (+33% in F4Q) & repurchases (guided +34% Y/Y to $2.4B results).
Bears Say
EarningsDHI reported F4Q EPS of $3.92 per share, below the $4.33 estimate and the $4.17 consensus.
GuidanceGuidance for F1Q25 and FY25 was below expectations, causing shares to fall 7%.
Market ConditionsBuyers are less motivated and affordability has been challenged, with traffic below expectations.
---
HO2 FAQ
What was DR Horton’s price range in the past 12 months?
DR Horton lowest stock price was €114.25 and its highest was €178.38 in the past 12 months.
What is DR Horton’s market cap?
Currently, no data Available
When is DR Horton’s upcoming earnings report date?
DR Horton’s upcoming earnings report date is Jan 28, 2025 which is in 64 days.
How were DR Horton’s earnings last quarter?
DR Horton released its earnings results on Oct 29, 2024. The company reported €3.698 earnings per share for the quarter, missing the consensus estimate of €3.934 by -€0.236.
Is DR Horton overvalued?
According to Wall Street analysts DR Horton’s price is currently Undervalued.
Does DR Horton pay dividends?
DR Horton pays a Quarterly dividend of €0.38 which represents an annual dividend yield of 0.73%. See more information on DR Horton dividends here
What is DR Horton’s EPS estimate?
DR Horton’s EPS estimate is €2.25.
How many shares outstanding does DR Horton have?
DR Horton has 321,169,530 shares outstanding.
What happened to DR Horton’s price movement after its last earnings report?
DR Horton reported an EPS of €3.698 in its last earnings report, missing expectations of €3.934. Following the earnings report the stock price went down -12.092%.
Which hedge fund is a major shareholder of DR Horton?
Among the largest hedge funds holding DR Horton’s share is Greenhaven Associates Inc. It holds DR Horton’s shares valued at 700M.
---
DR Horton Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€180.38 (17.10% Upside)
€180.38 (17.10% Upside)
Blogger Sentiment
Bullish
DE:HO2 Sentiment 85%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
29.80%
12-Months-Change
Fundamentals
Return on Equity
19.81%
Trailing 12-Months
Asset Growth
10.97%
Trailing 12-Months
Company Description
DR Horton
Founded in 1978, Texas-based D.R. Horton, Inc. is a homebuilding company that is engaged in the construction and sale of single-family homes through its diverse brand portfolio that includes D.R. Horton, Emerald Homes, Express Homes and Freedom Homes.
---
HO2 Company Deck
---
HO2 Earnings Call
Q4 2024
0:00 / 0:00
---
HO2 Revenue Breakdown
89.23% Home sales
7.35% Rental property sales
2.26% Financial services
1.16% Land/lot sales and other
---
HO2 Stock 12 Month Forecast
Average Price Target
€180.38
▲(17.10% Upside)
Technical Analysis
Best Analysts Covering HO2
1 Year
1 Year Success Rate
15/18 ratings generated profit
1 Year Average Return
+34.52%
reiterated a buy rating 27 days ago
Copying John Lovallo's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +34.52% per trade.
---